Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Understanding the role of access in Hispanic cancer screening disparities.

Tytuł:
Understanding the role of access in Hispanic cancer screening disparities.
Autorzy:
Spencer JC; Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Noel L; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Steve Hicks School of Social Work, University of Texas at Austin, Austin, Texas, USA.
Shokar NK; Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Pignone MP; Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Źródło:
Cancer [Cancer] 2023 May 15; Vol. 129 (10), pp. 1569-1578. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Comparative Study; Journal Article
Język:
English
Imprint Name(s):
Publication: <2005- >: Hoboken, NJ : Wiley
Original Publication: New York [etc.] Published for the American Cancer Society by J. Wiley [etc.]
MeSH Terms:
Early Detection of Cancer*/economics
Early Detection of Cancer*/statistics & numerical data
Health Services Accessibility*/economics
Health Services Accessibility*/statistics & numerical data
Healthcare Disparities*/economics
Healthcare Disparities*/ethnology
Healthcare Disparities*/statistics & numerical data
Hispanic or Latino*/statistics & numerical data
Neoplasms*/diagnosis
Neoplasms*/economics
Neoplasms*/epidemiology
Neoplasms*/ethnology
White*/statistics & numerical data
Female ; Humans ; Breast Neoplasms/diagnosis ; Breast Neoplasms/economics ; Breast Neoplasms/epidemiology ; Breast Neoplasms/ethnology ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/economics ; Colorectal Neoplasms/epidemiology ; Colorectal Neoplasms/ethnology ; Insurance Coverage/economics ; Insurance Coverage/statistics & numerical data ; Mass Screening/economics ; Mass Screening/statistics & numerical data ; United States/epidemiology ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/economics ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/ethnology
References:
Siu AL. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279-296. doi:10.7326/M15-2886.
Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/JAMA.2021.6238.
Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674-686. doi:10.1001/JAMA.2018.10897.
Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital signs: colorectal cancer screening test use - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(10):253-259. doi:10.15585/MMWR.MM6910A1.
Benavidez GA, Zgodic A, Zahnd WE, Eberth JM. Disparities in meeting USPSTF breast, cervical, and colorectal cancer screening guidelines among women in the United States. Prev Chronic Dis. 2021;18:E37. doi:10.5888/PCD18.200315.
Healthy People 2030. Cancer. Accessed February 8, 2023. https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer.
Suk R, Hong YR, Rajan SS, Xie Z, Zhu Y, Spencer JC. Assessment of US Preventive Services Task Force guideline-concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019. JAMA Netw Open. 2022;5(1):e2143582. Published online 2022. doi:10.1001/jamanetworkopen.2021.43582.
Patel AK. Disparities in access to screening for breast cancer: current state and potential solutions. J Am Coll Radiol. 2022;19(10):1119-1120. doi:10.1016/J.JACR.2022.08.002.
Fedewa SA, Jessica S, Priti B, et al. Changes in cancer screening during the COVID-19 pandemic: a population-based assessment. JAMA Netw Open. Published online 2022.
Qiao EM, Guram K, Kotha NV, et al. Association between primary care use prior to cancer diagnosis and subsequent cancer mortality in the Veterans Affairs health system. JAMA Netw Open. 2022;5(11):e2242048. doi:10.1001/JAMANETWORKOPEN.2022.42048.
Churchwell K, Elkind MSV, Benjamin RM, et al. Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association. Circulation. 2020;142(24):E454-E468. doi:10.1161/CIR.0000000000000936.
Alarcón RD, Parekh A, Wainberg ML, Duarte CS, Araya R, Oquendo MA. Hispanic immigrants in the USA: social and mental health perspectives. Lancet Psychiatry. 2016;3(9):860-870. doi:10.1016/S2215-0366(16)30101-8.
Wang F, Shu X, Pal T, et al. Racial/ethnic disparities in mortality related to access to care for major cancers in the United States. Cancers. 2022;14:3390. doi:10.3390/CANCERS14143390.
Tait SD, Ren Y, Horton CC, et al. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: a retrospective review of 90,000 women. Cancer. 2021;127:2515-2524. doi:10.1002/cncr.33473.
McDonald JA, Paulozzi LJ. Parsing the paradox: Hispanic mortality in the US by detailed cause of death. J Immigr Minority Health. 2019;21(2):237-245. doi:10.1007/S10903-018-0737-2/FIGURES/1.
Sarraju A, Ngo S, Ashland M, Scheinker D, Rodriguez F. Trends in national and county-level hispanic mortality in the United States, 2011-2020. Sci Rep. 2022;12(1):11812. doi:10.1038/s41598-022-15916-x.
Buchmueller TC, Levy HG. The ACA’s impact on racial and ethnic disparities in health insurance coverage and access to care. Health Aff. 2020;39(3):395-402. doi:10.1377/HLTHAFF.2019.01394/ASSET/IMAGES/LARGE/FIGUREEX3.JPEG.
Khullar D, Chokshi DA. Health, income, & poverty: where we are & what could help. Health Aff. Published online October 2018. doi:10.1377/HPB20180817.901935.
Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med. 2019;123:197-203. doi:10.1016/j.ypmed.2019.03.037.
Friedman AS, Thomas S, Suttiratana SC. Differences in cancer screening responses to state medicaid expansions by race and ethnicity, 2011-2019. Am J Publ Health. 2022;112(11):1630-1639. doi:10.2105/AJPH.2022.307027.
Spencer JC, Kim JJ, Wang L, et al. Racial and ethnic disparities in the cervical cancer screening cascade in three US health care settings. ASCO Qual Care Symp Proc. Published online September 2022. Accessed February 8, 2023. https://s3.amazonaws.com/files.oncologymeetings.org/prod/s3fs-public/2022-09/QCS22-Healthcare-Access-Equity-Disparities.pdf?jQVMUC4zk0mh1vyvSRopRg_3lB3Xh3WF.
Shih YCT, Elting LS, Levin B. Disparities in colorectal screening between US-born and foreign-born populations: evidence from the 2000 National Health Interview Survey. J Cancer Educ. 2008;23(1):18-25. doi:10.1080/08858190701634623.
Cofie LE, Hirth JM, Cuevas AG, Farr D. A national study of gender and racial differences in colorectal cancer screening among foreign-born older adults living in the US. J Behav Med. 2020;43(3):460-467. doi:10.1007/S10865-019-00107-3.
Banegas MP, Bird Y, Moraros J, King S, Prapsiri S, Thompson B. Breast cancer knowledge, attitudes, and early detection practices in United States-Mexico border latinas. J Wom Health. 2012;21(1):101-107. doi:10.1089/jwh.2010.2638.
Winters S, Alomari A, Shokar G, Martin C, Dwivedi A, Shokar NK. Breast cancer screening outcomes among Mexican-origin Hispanic women participating in a breast cancer screening program. Prev Med Rep. 2021;24:101561. doi:10.1016/J.PMEDR.2021.101561.
Moriarity C, Parsons V, Jonas K. Overview of the 2016-2025 national health interview survey sample design. In: Proceedings of the Joint Statistical Meetings, Survey Research Methods Section. Published online 2019. Accessed February 8, 2023. http://www.asasrms.org/Proceedings/y2019/files/1199603.pdf.
Ingram DD, Franco S. 2013 NCHS Urban-Rural Classification Scheme for Counties Series 2, Number 166. National Center for Health Statistics; 2014.
Kitagawa EM. Components of a difference between two rates. J Am Stat Assoc. 1955;50(272):1168. doi:10.2307/2281213.
Fairlie RW. An extension of the blinder-oaxaca decomposition technique to logit and probit models. J Econ Soc Meas. 2005;30(4):305-316. doi:10.3233/JEM-2005-0259.
Leeper TJ. Margins: marginal effects for model objects; 2021. Accessed February 8, 2023. https://thomasleeper.com/margins/.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2021. https://www.R-project.org/.
Miller KD, Ortiz AP, Pinheiro PS, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA: A Cancer J Clin. 2021;71(6):466-487. doi:10.3322/CAAC.21695.
Shokar NK, Vernon SW, Weller SC. Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Clin Res Methods. 2005;37:341-347.
Byrd TL, Calderón-Mora J, Salaiz R, Shokar NK. Barriers and facilitators to colorectal cancer screening within a Hispanic population. Hispanic Health Care Int: Off J Natl Assoc Hispanic Nurses. 2019;17(1):23-29. doi:10.1177/1540415318818982.
Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008;21(5):414-426. doi:10.3122/JABFM.2008.05.070266.
Sohler NL, Jerant A, Franks P. Socio-psychological factors in the expanded health belief model and subsequent colorectal cancer screening. Patient Educ Counsel. 2015;98(7):901-907. doi:10.1016/J.PEC.2015.03.023.
Kindratt TB, Dallo FJ, Allicock M, Atem F, Balasubramanian BA. The influence of patient-provider communication on cancer screenings differs among racial and ethnic groups. Prev Med Rep. 2020;18:18. doi:10.1016/J.PMEDR.2020.101086.
Jerome-D’emilia B. A systematic review of barriers and facilitators to mammography in hispanic women. J Transcult Nurs: Off J Transcult Nurs Soc. 2015;26(1):73-82. doi:10.1177/1043659614530761.
Kotzur M, McCowan C, MacDonald S, et al. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: A comparative qualitative study. BMJ Qual Saf. 2020;29(6):482-490. doi:10.1136/BMJQS-2019-009998.
Gonzalez P, Castaneda SF, Mills PJ, Talavera GA, Elder JP, Gallo LC. Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women. J Community Health. 2012;37(2):421-433. doi:10.1007/S10900-011-9459-2.
Luque JS, Logan A, Soulen G, et al. Systematic review of mammography screening educational interventions for Hispanic women in the United States. J Cancer Educ: Off J Am Assoc Cancer Educ. 2019;34(3):412-422. doi:10.1007/S13187-018-1321-0.
Nuño T, Martinez ME, Harris R, García F. A promotora-administered group education intervention to promote breast and cervical cancer screening in a rural community along the U.S.-Mexico border: a randomized controlled trial. Cancer Causes Control: CCC. 2011;22(3):367-374. doi:10.1007/S10552-010-9705-4.
Jacobsen GD, Jacobsen KH. Health awareness campaigns and diagnosis rates: Evidence from national breast cancer awareness month. J Health Econ. 2011;30(1):55-61. doi:10.1016/J.JHEALECO.2010.11.005.
Tangka FKL, Ohara B, Gardner JG, et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control. 2010;21(7):1081-1090. doi:10.1007/S10552-010-9536-3/FIGURES/1.
Tangka FKL, Dalaker J, Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (united states). Cancer Causes Control. 2006;17(9):1145-1154. doi:10.1007/s10552-006-0058-y.
Levano W, Miller JW, Leonard B, et al. Public education and targeted outreach to underserved women through the national breast and cervical cancer early detection program. Cancer. 2014;120(S16):2591-2596. doi:10.1002/CNCR.28819.
Ekwueme DU, Howard DH, Gelb CA, Rim SH, Cooper CP. Analysis of the benefits and costs of a national campaign to promote colorectal cancer screening: CDC’s screen for life-national colorectal cancer action campaign. Health Promot Pract. 2014;15(5):750-758. doi:10.1177/1524839913519446.
Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(12):1645-1658. doi:10.1001/JAMAINTERNMED.2018.4637.
Colorectal cancer control program. Centers for Disease Control and Prevention. Published May 2022. https://www.cdc.gov/cancer/crccp/index.htm.
Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314(15):1615-1634. doi:10.1001/jama.2015.13183.
Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med. 2018;111:177-179. doi:10.1016/J.YPMED.2018.03.011.
Lawson MB, Bissell MCS, Miglioretti DL, et al. Multilevel factors associated with time to biopsy after abnormal screening mammography results by race and ethnicity. JAMA Oncol. 2022;8:1115. doi:10.1001/JAMAONCOL.2022.1990.
Wheeler SB, O’leary MC, Rhode J, et al. Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit. Wiley Online Libr. 2020;15:2020. doi:10.1002/cncr.32992.
Pignone M, Lanier B, Kluz N, Valencia V, Chang P, Olmstead T. Effectiveness and cost-effectiveness of mailed FIT in a safety net clinic population. J Gen Intern Med. 2021;36(11):3441-3447. doi:10.1007/S11606-021-06691-Y.
White A, Thompson TD, White MC, et al. Cancer screening test use - United States, 2013. Morb Mortal Weekl Rep. 2015;64:464. doi:10.15585/mmwr.mm6608a1.
Sabatino SA, Thompson TD, White MC, et al. Cancer screening test receipt - United States, 2018. MMWR: Morb Mortal Wkly Rep. 2021;70(2):29-35. doi:10.15585/MMWR.MM7002A1.
Smith JS, Marais ACD, Deal AM, et al. Mailed human papillomavirus self-collection with Papanicolaou test referral for infrequently screened women in the United States. Sex Transm Dis. 2018;45(1):42-48. doi:10.1097/OLQ.0000000000000681.
Champion CD, Thomas SM, Plichta JK, et al. Disparities at the intersection of race and ethnicity: examining trends and outcomes in Hispanic women with breast cancer. JCO Oncol Pract. 2022;18(5):e827-e838. doi:10.1200/op.20.00381.
Swami N, Nguyen T, Dee EC, et al. Disparities in primary breast cancer stage at presentation among Hispanic subgroups. Ann Surg Oncol. 2022;29(13):7977-7987. doi:doi:10.1245/S10434-022-12302-9/TABLES/2.
Erwin DO, Treviño M, Saad-Harfouche FG, Rodriguez EM, Gage E, Jandorf L. Contextualizing diversity and culture within cancer control interventions for Latinas: changing interventions, not cultures. Soc Sci Med (1982). 2010;71(4):693-701. doi:10.1016/J.SOCSCIMED.2010.05.005.
Weinick RM, Jacobs EA, Stone LC, Ortega AN, Burstin H. Hispanic healthcare disparities: challenging the myth of a monolithic Hispanic population. Med Care. 2004;42(4):313-320. doi:10.1097/01.mlr.0000118705.27241.7c.
Rauscher GH, Johnson TP, Young IC, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17(4):748-757. doi:10.1158/1055-9965.EPI-07-2629.
Contributed Indexing:
Keywords: breast; cancer; cervical; colorectal; equity; screening
Entry Date(s):
Date Created: 20230214 Date Completed: 20230429 Latest Revision: 20230429
Update Code:
20240105
DOI:
10.1002/cncr.34696
PMID:
36787126
Czasopismo naukowe
Background: Hispanic populations in the United States experience numerous barriers to care access. It is unclear how cancer screening disparities between Hispanic and non-Hispanic White individuals are explained by access to care, including having a usual source of care and health insurance coverage.
Methods: A secondary analysis of the 2019 National Health Interview Survey was conducted and included respondents who were sex- and age-eligible for cervical (n = 8316), breast (n = 6025), or colorectal cancer screening (n = 11,313). The proportion of ever screened and up to date for each screening type was compared.  Regression models evaluated whether controlling for reporting a usual source of care and type of health insurance (public, private, none) attenuated disparities between Hispanics and non-Hispanic White individuals.
Results: Hispanic individuals were less likely than non-Hispanic White individuals to be up to date with cervical cancer screening (71.6% vs. 74.6%) and colorectal cancer screening (52.9% vs. 70.3%), but up-to-date screening was similar for breast cancer (78.8% vs. 76.3%). Hispanic individuals (vs. non-Hispanic White) were less likely to have a usual source of care (77.9% vs. 86.0%) and more likely to be uninsured (23.6% vs. 7.1%). In regressions, insurance fully attenuated cervical cancer disparities. Controlling for both usual source of care and insurance type explained approximately half of the colorectal cancer screening disparities (adjusted risk difference: -8.3 [-11.2 to -4.8]).
Conclusion: Addressing the high rate of uninsurance among Hispanic individuals could mitigate cancer screening disparities. Future research should build on the relative successes of breast cancer screening and investigate additional barriers for colorectal cancer screening.
Plain Language Summary: This study uses data from a national survey to compare cancer screening use those who identify as Hispanic with those who identify as non-Hispanic White. Those who identify as Hispanic are much less likely to be up to date with colorectal cancer screening than those who identify as non-Hispanic White, slightly less likely to be up to date on cervical cancer screening, and similarly likely to receive breast cancer screening. Improving insurance coverage is important for health equity, as is further exploring what drives higher use of breast cancer screening and lower use of colorectal cancer screening.
(© 2023 American Cancer Society.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies